Genmab A (GMAB) Inventory Average (2023 - 2026)

Genmab A (GMAB) has reported Inventory Average for 4 consecutive years, with $19.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 56.0% year-over-year to $19.5 million; the trailing twelve-month figure through Jun 2026 stood at $19.5 million (up 56.0% YoY), and the FY2025 full-year result was $15.0 million, changed N/A from the prior year.
• Inventory Average held at $19.5 million in Q2 2026 per GMAB's latest filing, from $19.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $19.5 million in Q1 2026 and bottomed at $5.1 million in Q3 2024.
• Historically, Inventory Average has averaged $11.0 million across 4 years, with a median of $9.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory Average declined 21.2% in 2024, then jumped 165.06% in 2025.
• Over 4 years, Inventory Average stood at $8.0 million in 2023, then slipped by 21.2% to $6.3 million in 2024, then soared by 154.28% to $16.0 million in 2025, then increased by 21.88% to $19.5 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $19.5 million, $19.5 million, and $16.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.